
Commentary|Podcasts|May 23, 2022
Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer
Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.
Advertisement
In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
3
What Pharmacists Should Know About the Ifosfamide Shortage
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5






































































































